What is the English name of Trametinib? Let me tell you in one article!

Trametinib is a targeted therapy drug mainly used to treat certain types of malignant tumors, especially melanoma, thyroid cancer and non-small cell lung cancer related to BRAF gene mutations. Its English name"Trametinib" is an internationally common name and is widely recognized in the medical and pharmaceutical fields. The trade name of trametinib is Mekinist, which is often used in clinical practice.

As aMEK inhibitor, trametinib can effectively block the intracellular RAS/RAF/MEK/ERK signaling pathway by specifically inhibiting the activity of MEK1 and MEK2. This signaling pathway is often overactivated in many tumor cells, promoting tumor growth and spread. Therefore, trametinib can exert significant anti-tumor effects by inhibiting the activity of this key signaling pathway.

In clinical applications, trametinib is usually used in combination with other targeted drugs, such as with dabrafenib (Dabrafenib) to treat patients with BRAF mutation-positive melanoma. This combination therapy not only enhances efficacy but also combats drug resistance in tumor cells. By jointly intervening in multiple key points, the combination of trametinib and dabrafenib can provide a more effective treatment plan and significantly improve patients' survival rate and quality of life.

As an oral drug, trametinib is relatively simple to administer, making it easier for patients to adhere to treatment in their daily lives. In clinical trials, the drug has demonstrated good safety and tolerability, with most patients able to tolerate the side effects of treatment well. In addition, trametinib can significantly improve the response rate and progression-free survival (PFS) of BRAF mutation-positive melanoma patients, thus occupying an important position in treatment selection.

Reference materials:https://go.drugbank.com/drugs/DB08911